Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 9—September 2023
Research

Compliance Trajectory and Patterns of COVID-19 Preventive Measures, Japan, 2020–2022

Taro Kusama, Kenji TakeuchiComments to Author , Yudai Tamada, Sakura Kiuchi, Ken Osaka, and Takahiro Tabuchi
Author affiliations: Tohoku University Graduate School of Dentistry, Sendai, Japan (T. Kusama, K. Takeuchi, Y. Tamada, S. Kiuchi, K. Osaka); Nagoya University Graduate School of Medicine, Nagoya, Japan (K. Takeuchi, Y. Tamada); Tohoku University Frontier Research Institute for Interdisciplinary Sciences, Sendai (S. Kiuchi); Osaka International Cancer Institute, Osaka, Japan (T. Tabuchi); The Tokyo Foundation for Policy Research, Tokyo, Japan (T. Tabuchi)

Main Article

Table 4

Associations (% difference) between each latent class and participant characteristic in study of compliance trajectory and patterns of COVID-19 preventive measures, Japan, 2020–2022*

Characteristic Low compliance
Personal hygiene
Avoiding social contact
Comprehensive
% Diff (95% CI) p value % Diff (95% CI) p value % Diff (95% CI) p value % Diff (95% CI) p value
Per wave†
–2.8 (–3.3 to −2.3)
<0.001

2.6 (2.1–3.0)
<0.001

0.4 (–0.1 to 1.0)
0.098

−0.2 (–0.7 to 0.3)
0.482
Survey
JACSIS Referent NA Referent NA Referent NA Referent NA
JASTIS
3.4 (2.6–4.2)
<0.001

–0.2 (–1.1 to 0.7)
0.618

–1.5 (–2.6 to –0.4)
0.008

–1.7 (–2.6 to –0.8)
<0.001
Sex
M Referent NA Referent NA Referent NA Referent NA
F
–15.8 (–17.0 to –14.7)
<0.001

2.1 (1.0–3.3)
<0.001

2.8 (1.4–4.3)
<0.001

10.7 (9.2–12.3)
<0.001
Age, y
20–29 Referent NA Referent NA Referent NA Referent NA
30–39 –7.8 (–10.5 to –5.2) <0.001 –1.0 (–3.3 to 1.3) 0.392 6.9 (4.9–8.8) <0.001 2.0 (–0.1 to 4.0) 0.052
40–49 –10.7 (–13.3 to –8.0) <0.001 –0.9 (–3.2 to 1.3) 0.402 8.5 (6.7–10.3) <0.001 3.1 (1.2–5.1) 0.002
50–59 –12.2 (–14.9 to –9.5) <0.001 –1.6 (–3.9 to 0.8) 0.189 12.2 (10.3–14.0) <0.001 1.6 (–0.4 to 3.5) 0.113
60–69 –13.4 (–16.1 to –10.8) <0.001 –3.8 (–6.1 to –1.5) 0.001 16.9 (14.8–19.0) <0.001 0.3 (–1.8 to 2.4) 0.757
70–79
–15.6 (–18.4 to –12.8)
<0.001

–9.7 (–12.4 to –7.1)
<0.001

22.8 (19.5–26.1)
<0.001

2.5 (–1.0 to 6.0)
0.160
Education
Junior high, high school Referent NA Referent NA Referent NA Referent NA
Vocational school, junior college –4.1 (–5.3 to –2.8) <0.001 0.1 (–1.2 to 1.3) 0.916 –0.6 (–2.0 to 0.7) 0.356 4.6 (3.3–6.0) <0.001
University, graduate school
–2.3 (–3.7 to –1.0)
0.001

–0.5 (–1.9 to 0.9)
0.460

–1.0 (–2.9 to 0.9)
0.300

3.8 (1.8–5.8)
<0.001
Equivalent income, million JPY 2.7 (–3.6 to 9.1) 0.404 –3.7 (–10.8 to 3.4) 0.307 –2.4 (–10.3 to 5.6) 0.556 3.4 (–2.8 to 9.6) 0.284
<2.00 Referent NA Referent NA Referent NA Referent NA
2.00–3.99 –3.4 (–5.1 to –1.6) <0.001 4.2 (2.7–5.7) <0.001 –0.9 (–2.9 to 1.0) 0.343 0.2 (–2.0 to 2.3) 0.889
4.00–5.99 –4.4 (–6.3 to –2.4) <0.001 5.0 (3.3–6.7) <0.001 –2.2 (–4.3 to –0.1) 0.040 1.6 (–0.6 to 3.8) 0.159
>6.00 –3.4 [–6.3 to –0.4) 0.024 6.6 (3.9–9.4) <0.001 –6.5 (–8.8 to –4.2) <0.001 3.2 (0.5–6.0) 0.022
Not answered
–2.7 (–4.6 to –0.8)
0.005

0.5 (–1.2 to 2.2)
0.560

–1.6 (–4.0 to 0.7)
0.179

3.8 (1.5–6.2)
0.001
Population density of residential prefecture
Low Referent NA Referent NA Referent NA Referent NA
High –0.3 (–1.5 to 1.0) 0.685 1.3 (0.1–2.5) 0.041 –4.1 (–5.6 to –2.7) <0.001 3.1 (1.6–4.6) <0.001

*Total number of responses was 103,312. Diff, difference; JACSIS, Japan COVID-19 and Society Internet Survey; JASTIS, Japan Society and New Tobacco Internet Survey; JPY, Japanese yen; NA, not applicable. †Surveys were conducted in 4 waves: August 25–September 30, 2020 (JACSIS2020); February 8–26, 2021 (JASTIS2021); September 27–October 29, 2021 (JACSIS2021); and February 1–28, 2022 (JASTIS2022).

Main Article

Page created: June 29, 2023
Page updated: August 20, 2023
Page reviewed: August 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external